The U.S. Food and Drug Administration (FDA) sent over 50 warning letters to GLP-1 drug compounders and manufacturers in September 2025. The agency warned the companies that their statements that ...
A July 14, 2025 U.S. Food & Drug Administration (FDA) warning letter to a prominent wellness product and services company offers a blunt reminder that medical device requirements cannot be waived or ...
New Jersey-based AACE Pharmaceuticals has been slammed in an FDA warning letter citing significant violations by its contract manufacturer Brassica Pharma, including substandard sanitary conditions ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or months ...
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or months ...
The US Food and Drug Administration (FDA) has followed up on its promise to clampdown on misleading and deceptive drug advertisements in the US, with the agency publishing a large batch of warning ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback